Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage

Aminoglycosides exhibit ototoxicity by damaging mitochondria, which in turn generate reactive oxygen species that induce hair cell death and subsequent hearing loss. It is well known that damaged mitochondria are degraded by mitophagy, an important mitochondrial quality control system that maintains mitochondrial homeostasis and ensures cell survival. However, it is unclear whether dysregulation of mitophagy contributes to aminoglycoside-induced hair cell injury. In the current study, we found that PINK1-PRKN-mediated mitophagy was impaired in neomycin-treated hair cells. Our data suggested that mitochondrial recruitment of PRKN and phagophore recognition of damaged mitochondria during mitophagy were blocked following neomycin treatment. In addition, the degradation of damaged mitochondria by lysosomes was significantly decreased as indicated by the mitophagic flux reporter mt-mKeima. Moreover, we demonstrated that neomycin disrupted mitophagy through transcriptional inhibition of Pink1 expression, the key initiator of mitophagy. Moreover, we found that neomycin impaired mitophagy by inducing ATF3 expression. Importantly, treatment with a mitophagy activator could rescue neomycin-treated hair cells by increasing mitophagy, indicating that genetic modulation or drug intervention in mitophagy may have therapeutic potential for aminoglycoside-induced hearing loss.

Automated summary

This study found that aminoglycosides cause hair cell injury by impairing mitophagy, a process that degrades damaged mitochondria. The impaired mitophagy is characterized by blocked recruitment of PRKN to mitochondria and phagophore recognition of damaged mitochondria. Additionally, neomycin disrupts mitophagy by inhibiting Pink1 expression and inducing ATF3 expression. Treatment with a mitophagy activator can rescue neomycin-treated hair cells by increasing mitophagy. Overall, this study suggests that modulating or intervening in mitophagy may have therapeutic potential for aminoglycoside-induced hearing loss.